Pricing

Lumos Pharma Inc (LUMO)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Richard J. Hawkins
Employees:
30
4200 MARATHON BLVD., SUITE 200, AUSTIN, TX, 78756
512-215-2630
    Formally known as:
  • LUMOS PHARMA ORD SHS
Stock Split History
DateRatio
2020-03-19 0.125
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available